Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in CALGB 50401 (Alliance)

Adverse events (AEs) from chronically administered oral agents treating hematologic malignancies may affect patients’ ability to tolerate treatment over time. Conventional toxicity tables emphasizing incidence of high grade AEs do not provide information on AE time profile or reflect continuous lowe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Haematol
Main Authors: Thanarajasingam, Gita, Leonard, John P., Witzig, Thomas E., Habermann, Thomas M., Blum, Kristie A., Bartlett, Nancy L., Flowers, Christopher R., Pitcher, Brandelyn N., Jung, Sin-Ho, Atherton, Pamela J., Tan, Angelina, Novotny, Paul J., Dueck, Amylou C.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457391/
https://ncbi.nlm.nih.gov/pubmed/32470440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(20)30067-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares